71 results
Page 2 of 4
6-K
EX-99.2
vu7iih
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
nu91a90t k5n
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
chu95
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.2
y9njwyoh2
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
rqoxsda
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am
6-K
EX-99.2
niup3dv1eec5t8omll8j
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.1
df7l0of8cf 5fk4n
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.3
i42v52dtc66e
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
7hz85pz gv8n9
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
s9cday7j 9khu
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.2
dd2 e42ku1
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
e4zl9t30r
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
wp1q1ns
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.2
46fsr3 i0t1df
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
aqqg 9t4keix3vv
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
sks5hjnurr8f6gv87f6s
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.2
rx7 f952x86385mkdhz
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
54jk56zayb16
11 May 21
Current report (foreign)
2:10pm